PRS31 - Cost Effectiveness of Tobramycin Versus Azithromycin as First-Line Therapy for Acute Exacerbations Among Patients with Non-Cystic Fibrosis Bronchiectasis

Saved in:
Bibliographic Details
Published inValue in health Vol. 21; p. S235
Main Authors Patel, RP, Clark, LA, Parvathagiri, V, Noone, JM, Blanchette, CM, Howden, R
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.05.2018
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2018.04.1594